Introducing the New Cagrilintide ELISA Kit

We are excited to launch our Cagrilintide ELISA Kit S-1553, a powerful tool designed to deliver high sensitivity, reproducibility, and ease of use in detecting and quantifying Cagrilintide in serum or plasma samples.

Whether you are advancing preclinical models or supporting clinical studies, this assay is built to meet the rigorous demands of metabolic research.

Key Features:

✅ High Sensitivity – Detect low nanogram concentrations

✅ Rapid Protocol – Streamlined workflow with minimal hands-on time

✅ Validated Performance – Consistent, reproducible results

✅ Flexible Use – Compatible with mouse, rat, human samples, and others

 

Why It Matters:

Cagrilintide, a long-acting amylin analogue, is a promising therapeutic for obesity and appetite regulation. Having the right tools to measure it accurately is critical for meaningful research outcomes.

This ELISA kit is your new gold standard.

Be among the first to integrate this essential tool into your research pipeline and contact us at info@bma.ch

We help you keep your research moving forward!

Your BMA team

 

 

Copyright © BMA Biomedicals 2025